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Abstract 42 
Chronic Pseudomonas aeruginosa lung infection is characterized by the presence of endobronchial 43 
antibiotic-tolerant biofilm subject to strong oxygen (O2) depletion due to the activity of surrounding 44 
polymorphonuclear leukocytes. The exact mechanisms affecting the antibiotic susceptibility of 45 
biofilms remain unclear, but accumulating evidence suggests that the efficacy of several 46 
bactericidal antibiotics is enhanced by stimulation of aerobic respiration of pathogens, while lack of 47 
O2 increases their tolerance. In fact, the bactericidal effect of several antibiotics depends on active 48 
aerobic metabolism activity and the endogenous formation of reactive O2 radicals (ROS). In this 49 
study we aimed to apply hyperbaric oxygen treatment (HBOT) in order to sensitize anoxic P. 50 
aeruginosa agarose-biofilms established to mimic situations with intense O2 consumption by the 51 
host response in the cystic fibrosis (CF) lung. Application of HBOT resulted in enhanced 52 
bactericidal activity of ciprofloxacin at clinically relevant durations and was accompanied by 53 
indications of restored aerobic respiration, involvement of endogenous lethal oxidative stress and 54 
increased bacterial growth. The findings highlight that oxygenation by HBOT improves the 55 
bactericidal activity of ciprofloxacin on P. aeruginosa biofilm and suggest that bacterial biofilms is 56 
sensitized to antibiotics by supplying hyperbaric O2. 57 
 58 
Introduction 59 
Chronic pulmonary infection with Pseudomonas aeruginosa in cystic fibrosis (CF) patients is the 60 
ﬁrst bioﬁlm infection described in humans (1). In CF patients, the chronic lung infection with P. 61 
aeruginosa constitutes the major cause of increased morbidity and mortality (2). Therefore, the 62 
dramatically increased tolerance of P. aeruginosa biofilms to antibiotics is a critical challenge for 63 
improving the antibiotic treatment of chronic lung infections in CF patients (3). Increased tolerance 64 
of P. aeruginosa biofilms to antibiotics is multi-factorial (4) and may to some extent depend on 65 
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restriction of molecular oxygen (O2) (5, 6), which is distributed at low levels reaching anoxia in 66 
parts of the endobronchial secretions of chronically infected CF patients (7-9). Since O2 is a 67 
prerequisite for aerobic respiration, shortage of O2 may decelerate aerobic respiration leading to 68 
increased tolerance to several antibiotics (10-12). This enhanced tolerance possibly relies on 69 
decreased expression of antibiotic targets and antibiotic uptake (13) as well as reduced endogenous 70 
lethal oxidative stress in response to downstream events resulting from interaction between drugs 71 
and targets (11, 12). In accordance, we have previously shown that re-oxygenation of O2 depleted 72 
P. aeruginosa biofilms using hyperbaric O2 treatment (HBOT) increases the susceptibility to 73 
ciprofloxacin (14). In that study the O2 was removed by bacterial aerobic respiration (14). However, 74 
this may be in contrast to the consumption of O2 in the endobronchial secretions of CF patients 75 
where the vast majority of O2 is consumed by the PMNs for production of reactive O2 species 76 
(ROS) and nitric oxide (NO) whereas only a minute part of O2 was consumed by aerobic respiration 77 
(8, 15). In fact, ongoing anaerobic respiration and low in vivo growth rates of P. aeruginosa 78 
biofilms (16) and of several other bacterial pathogens (17-19) suggest limited bacterial aerobic 79 
respiration (20). Therefore in order to mimic situations in CF lungs where intense O2 consumption 80 
by activated PMNs prevents engagement of bacterial aerobic respiration we have grown bacterial 81 
biofilm without O2 prior to antibiotic treatment and HBOT. Using this approach, we aimed to 82 
examine if absent aerobic respiration may be restored by HBOT for clinically relevant durations 83 
leading to increased bactericidal effect of ciprofloxacin.  84 
 85 
Results  86 
Effect of HBOT on P. aeruginosa biofilm during ciprofloxacin treatment. 87 
Significantly less PAO1 bacteria survived 90 min of treatment with ciprofloxacin when HBOT was 88 
applied (p < 0.0001, n =13-19) (Fig. 1a). The maximum enhancement of bacterial killing by HBOT 89 
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exceeded 2 log units when supplemented with 0.5 mg L-1 of ciprofloxacin indicating that HBOT 90 
exposed P. aeruginosa biofilm can be treated with lower ciprofloxacin concentrations than controls.  91 
It is striking that the potentiation of ciprofloxacin is stronger after 90 min of HBOT than for 2 h of 92 
HBOT as previously reported (14). However, the present model has been developed to better 93 
represent the in vivo microenvironment where P. aeruginosa is deprived of O2 due to intense O2 94 
depletion by the surrounding PMNs creating anoxia (8). Furthermore, the depth of the agarose 95 
embedded biofilm has been decreased in order for O2 to penetrate through larger parts of entire 96 
biofilm within 90 min.  97 
In P. aeruginosa a major part of detoxification of ROS is contributed by catalase enzymes encoded 98 
by the katA gene (21, 22). Accordingly, the increased susceptibility to antibiotics in mutants with 99 
defective katA expression as well as enhanced tolerance to antibiotics in mutants with 100 
overexpression of catalase are recognized as direct evidence for a lethal effect of ROS generation 101 
during antibiotic treatment (12, 23, 24). 102 
Therefore we employed ΔkatA biofilms to elucidate that ROS play a role in the increased lethality 103 
of ciprofloxacin during HBOT. We found significantly less ΔkatA bacteria surviving 90 min of 104 
treatment with ciprofloxacin when HBOT was applied compared with PAO1 biofilms (p < 0.0024, 105 
n = 11-14), demonstrating a contribution of oxidative stress to decreased bacterial survival (Fig 1b). 106 
This indicates that HBOT enabled aerobic respiration allowing ciprofloxacin to induce formation of 107 
lethal amounts of ROS (10). However, an increased susceptibility of ΔkatA was only seen for the 108 
higher concentrations of ciprofloxacin suggesting that other anti-oxidative mechanisms protects 109 
against the ROS produced during treatment with low amounts of ciprofloxacin (10).  110 
 111 
 112 
 113 
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HBOT expands the bactericidal zone of ciprofloxacin treatment in P. aeruginosa biofilm. 114 
P. aeruginosa embedded in agarose that grows in discrete aggregates was detected by confocal 115 
microscopy (Fig 2) (25). Variations in aggregate size may depend on whether initiation is from 116 
single or multiple cells. Aggregate diameter was significantly larger after 90 min of HBOT (100 % 117 
O2, 2.8 bar) than after anoxia (median diameter (range) (µm)): 37 µm (9-193) vs 23 (7-66); p < 118 
0.0001, n = 139) estimated from live/dead staining of samples without ciprofloxacin treatment in 119 
the upper 100 µm of the agarose embedded biofilm. Aggregate volume was 4.2 fold larger after 90 120 
min of HBOT than after anoxia (median volume (µm3): 27 vs 6.4, n = 139), indicative of 4.2 fold 121 
more bacterial cells and an additional 2 divisions compared to anoxic treatment. Furthermore, the PI 122 
experiments were intended to confirm the statistically significant difference found with CFU 123 
counting and to visualize the increased zone of bactericidal activity caused by HBOT during 124 
ciprofloxacin treatment.  125 
 126 
HBOT stimulates growth in P. aeruginosa biofilm. 127 
Untreated PAO1 biofilms embedded in agarose were exposed to HBOT with a significantly 128 
increased bacterial growth demonstrated during the 90 min of incubation (p < 0.0001, n =19). 129 
Compared with growth under anoxic conditions, HBOT increased the density of PAO1 biofilms 130 
without antibiotic treatment indicating that aerobic respiration increases bacterial growth (Fig 3). In 131 
fact, 90 min of HBOT increased the bacterial growth by ½ log as compared to anaerobic growth.  132 
 133 
Distribution of O2 in P. aeruginosa biofilm after HBOT 134 
Vertical profiling of O2 concentration in the agarose-embedded biofilm immediately after 135 
termination of 90 minutes of HBOT, demonstrated O2 concentrations exceeding 1000 μmol L-1 in 136 
the media above the biofilm surface (Fig 4). Serial profiling revealed both rapid depletion of O2 in 137 
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the upper part of the biofilm and O2 diffusion from the supernatant to the normobaric atmosphere. 138 
However, within 20 min post HBOT, the zone of O2 depletion inside the biofilm was expanded and 139 
the O2 concentration of the supernatant decreased below atmospheric saturation, indicating that 140 
PAO1 was utilising the available O2 for aerobic respiration until O2-depletion in the biofilm would 141 
necessitate conversion to anaerobic respiration (Fig 4). 142 
O2 diffusion through the agarose gel alone was detected at agarose concentrations from 0.125% to 143 
2%. As expected (26), no significant concentration dependence or deviation from free diffusion was 144 
observed and accordingly the assumption made that O2 diffusion is not hindered by agarose or 145 
water in the biofilm model (data not shown). 146 
Ciprofloxacin efficacy is known to be linked to growth in view of the quinolone target’s increased 147 
activity during DNA replication both planktonically and in biofilms (27, 28). However, the inability 148 
to respire during aerobic respiration allows bacteria to arrest growth in a manner that increases 149 
tolerance. This study shows that addition of O2 sensitizes bacteria by stimulating growth in areas 150 
deprived of O2. It has been shown previously that quinolones also have a bactericidal effect on 151 
flow-cell biofilms, but that subpopulations remained tolerant to treatment. Similarly, our results on 152 
non-attached biofilm reflecting a more accurate representation of chronic lung infection show a 153 
bactericidal effect of ciprofloxacin improved with HBOT. 154 
 155 
Discussion  156 
P. aeruginosa is clinically a very important respiratory pathogen that causes the most severe 157 
complication of chronic lung infection in CF patients (2). Throughout the chronic infection state, 158 
microbial biofilms form as cell aggregates and become trapped in the endobronchial mucus (29) 159 
with the host response creating chemical microenvironments favouring bacterial physiology 160 
associated with tolerance against multiple antibiotics (20). Therefore, new treatment strategies are 161 
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required to overcome these resilient bacterial infections HBOT has beneficial effects on the 162 
treatment of a number of infectious diseases, clinically, experimentally and in vitro (14, 20, 30)  163 
although whether these can be expanded to biofilm infections has not been extensively examined. 164 
The present study utilised a model in which anoxic P. aeruginosa was embedded in an agarose gel, 165 
trapping bacteria as aggregates throughout the gel in order to mimic biofilm infection in vivo (14, 166 
30-32).  167 
Few studies have shown that HBOT can be used as an adjuvant to ciprofloxacin treatment on P. 168 
aeruginosa (33, 34) and to our knowledge our recently published proof-of-concept study provided 169 
the first demonstration that HBOT can enhance the bactericidal activity of ciprofloxacin on biofilms 170 
(14). In the present study it has been substantiated that bactericidal activity of ciprofloxacin is 171 
enhanced after only 90 minutes of HBOT, representing a typical time frame used clinically for 172 
HBOT (35, 36). The Undersea and Hyperbaric Medical Society recommends 90 to 120 min of 173 
HBOT per session (37). Prior to HBOT, bacterial growth supported by aerobic respiration in the 174 
biofilm model was prevented by O2 exclusion while addition of NO3- enabled anaerobic respiration 175 
by denitrification (38, 39). The rapid decrease from hyperoxia to hypoxia demonstrated by serial 176 
measurements of O2 concentration profiles in the biofilm immediately after HBOT indicated 177 
engagement of aerobic bacterial respiration during HBOT with this metabolic shift likely explaining 178 
the observation of faster growth of PAO1 under HBOT (40). Induction of increased metabolic 179 
activity by HBOT was further indicated by increased SYTO9 fluorescence intensity and bacterial 180 
aggregate size after HBOT resembling colonies in metabolically active zones in similar biofilm 181 
models (31, 41). 182 
Consequentially, activation of aerobic respiration by HBOT may contribute to the enhanced 183 
bactericidal activity of ciprofloxacin by accelerating bacterial growth, as the susceptibility to 184 
ciprofloxacin of P. aeruginosa biofilm is correlated to growth rate (42).  185 
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In addition to a growth-related enhancement of ciprofloxacin treatment during HBOT, it was 186 
speculated that HBOT induced re-oxygenation of the biofilm leads to accumulation of cytotoxic 187 
ROS in response to ciprofloxacin. Induction of endogenous production of cytotoxic ROS has been 188 
shown to contribute to the aerobic killing of planktonic bacteria by several major classes of 189 
antibiotics (11, 12, 43) including aerobic P. aeruginosa biofilms (44) although the significance of 190 
this has been challenged (11, 45, 46). However, increased susceptibility to antibiotics of mutants 191 
with deficient anti-oxidative defence is regarded as solid indication for a contribution of ROS to the 192 
bactericidal effect of antibiotics (23). Thus, the increased killing of the ΔkatA-mutant in our study 193 
supports that endogenous generation of ROS can contribute to an enhanced bactericidal effect of 194 
ciprofloxacin on biofilm during adjuvant HBOT. Growth of ΔkatA was not impaired with HBOT in 195 
the absence of ciprofloxacin treatment as compared to the wild-type, indicating a lack of cytotoxic 196 
ROS generation by HBOT alone (data not shown). 197 
Biofilm infections are notoriously difficult to eradicate with antimicrobial treatment, as frequently 198 
higher concentrations of antibiotics are required for killing of biofilms compared to planktonic 199 
bacteria, with these concentrations being difficult to match in vivo (47). Our finding of a 200 
significantly increased bacterial killing during HBOT with only 2 x MIC and 4 x MIC of 201 
ciprofloxacin indicates that by using HBOT, P. aeruginosa biofilms can be effectively treated with 202 
lower ciprofloxacin levels, that are attainable in vivo.  203 
Although still controversial, there is an increasing acceptance of the advantages of HBOT with a 204 
small number of studies focusing on the use of HBOT on biofilm infections e.g. associated with 205 
periodontal disease, osteomyelitis and chronic wounds (48-50). The effect of HBOT on biofilm 206 
infections in the pulmonary system remain largely unknown, though some studies have 207 
demonstrated the beneficial effect of HBOT in patients with acute abscesses and in experimental 208 
pulmonary infection models with P. aeruginosa (51, 52). The feasibility of HBOT to sensitize 209 
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infectious biofilm to antibiotics in patients is indicated by the fact of PAO1 being a clinical isolate 210 
from a burn wound (53, 54). In addition, we have recently demonstrated potentiation of tobramycin 211 
by HBOT on both in vitro and in vivo biofilms of clinical isolate of Staphylococcus aureus (55). 212 
However, a better understanding of the usefulness of HBOT in CF patients awaits further 213 
experiments with pathogens isolated longitudinal as well as isolates with known resistance 214 
including highly resistant strains.  The risk of development of barotrauma in the lungs, however, 215 
should raise concerns when applying HBOT to patients with severely damaged lung tissue.  216 
In summary, the findings of this study point to a new treatment strategy for biofilm infections by 217 
providing HBOT as an adjuvant to ciprofloxacin treatment, where the increased availability of O2 218 
leads to an increased susceptibility of P. aeruginosa biofilms to clinically relevant concentrations of 219 
antibiotic. 220 
 221 
Materials and methods  222 
Bacterial strains, media and antibiotics 223 
Wild-type P. aeruginosa strain PAO1 was obtained from the Pseudomonas Genetic Stock Centre 224 
(http://www.pseudomonas.med.ecu.edu). Both the wild-type and a catalase A negative PAO1 225 
(ΔkatA) mutant (22) were tested for susceptibility to the bactericidal antibiotic ciprofloxacin (Bayer 226 
GmbH, Leverkusen, Germany). katA encodes the catalase enzyme responsible for the major part of 227 
detoxification of ROS in P. aeruginosa and accordingly the ΔkatA mutant was chosen to 228 
demonstrate ROS contribution to ciprofloxacin activity. The minimum inhibitory concentration 229 
(MIC) of PAO1 was 0.125 mg L-1 as determined by Etest (BioMérieux, Ballerup, Denmark). 230 
Growth was in Lysogeny broth (LB) [5 g L-1 yeast extract (Oxoid, Basingstoke, UK), 10 g L-1 231 
tryptone (Oxoid) and 10 g L-1 NaCl (Merck, Rahway, NJ), pH 7.5], incubated overnight at 37◦C and 232 
shaken at 150 rpm. For determination of bacterial CFU counts, solid lactose agar plates (‘Blue 233 
 o
n
 Septem
ber 11, 2017 by DTU Library
http://aac.asm
.org/
D
ow
nloaded from
 
12 
 
plates’ based on a modified Conradi–Drigalski medium containing 10 g L-1 detergent, 1 g L-1  234 
Na2S2O3·H2O, 0.1 g L-1 bromothymolblue, 9 g L-1 lactose and 0.4 g L-1 glucose, pH 8.0; Statens 235 
Serum Institut, Copenhagen, Denmark) were used to select for Gram-negative bacteria. All plates 236 
were incubated overnight at 37◦C. 237 
 238 
Anaerobic growth  239 
P. aeruginosa biofilms were grown and treated under anoxic conditions in an anaerobic growth 240 
chamber (Concept 400 Anaerobic Workstation, Ruskinn Technology Ltd, UK). The gas atmosphere 241 
consisted of N2/H2/CO2 (ratio - 80:10:10). Anoxia was confirmed with an optical O2 sensor (HQ40d 242 
multi, HACH Company, CO, US) placed in the growth chamber. To remove traces of O2, all media 243 
and chemical solutions applied for anaerobic work were equilibrated in the anaerobic chamber 3 244 
days prior to experiment.  245 
 246 
Susceptibility testing of mature biofilms 247 
Survival curves were assayed to investigate the effect of HBOT on P. aeruginosa biofilms treated 248 
with ciprofloxacin during 90 min. Overnight cultures of PAO1 or ΔkatA optical density at 600 nm 249 
(OD600) was adjusted to 0.4 before 100-fold dilution in LB medium supplemented with 2 % 2-250 
hydroxyethyl-agarose (Sigma–Aldrich, Brøndby, Denmark) and 50 µL loaded into 96-well 251 
microtiter plates (Nucleon Delta Surface; Thermo Fisher Scientific, Waltham, MA, USA) to 252 
achieve a cell loading of ≈ 106 cells mL-1. The medium was supplemented with NaNO3 (1 mM) 253 
(Sigma–Aldrich) to enable anaerobic respiration. The supernatant was replaced daily with 50 μL of 254 
LB medium supplemented with 1 mM NaNO3. Microtiter plates were covered with Parafilm 255 
(Bemis, Neenah, WI, USA) and lid and were incubated under anoxic conditions at 37◦C for 3 days 256 
to establish mature biofilms. The density of mature untreated PAO1 and ΔkatA biofilms was 7.7 x 257 
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106 CFU mL−1 and 7.6 x 106 CFU mL−1 under anaerobic growth conditions. Treatment with 258 
ciprofloxacin was initiated by replacing the supernatant with 50 μL of a ciprofloxacin solution in 259 
LB medium (supplemented with 1 mM NO3−) in two-fold dilutions from 0 to 2 mg L-1. The plates 260 
were then further incubated for 90 min under anoxic or HBO conditions. At the termination of 261 
experiments, the supernatant was discarded and the agarose-embedded PAO1 biofilms were placed 262 
in 2.95 mL of phosphate-buffered saline (PBS) (Substrate Department, Panum Institute, 263 
Copenhagen, Denmark) before re-suspension for 15–20s in a homogenizer (SilentCrusher M; 264 
Heidolph, Schwabach, Germany). Quantitative bacteriology was performed by standard 265 
microbiological methods incubated overnight at 37◦C. 266 
 267 
Hyperbaric oxygen treatment 268 
Agarose-embedded bacteria were exposed to HBOT (100% O2) at a pressure of 280 kPa (2.8 bar) at 269 
37oC in a hyperbaric oxygen chamber (OXYCOM 250 ARC; Hypcom Oy, Tampere, Finland). The 270 
HBOT sequence consisted of pressurization over 5 min to a pressure of 280 kPa. The pressure was 271 
then applied for 90 min followed by 5 min of decompression. A constant temperature at 37oC in the 272 
biofilm samples was established by a circulating water system heater (FL300, Julabo, Seelbach, 273 
Germany) placed underneath the microtiter plates in the hyperbaric oxygen chamber. 274 
 275 
Sectioning and microscopy of agarose embedded biofilm samples 276 
Larger amounts of agarose-embedded biofilms were grown anaerobically with NO3- for 3 days in 277 
24-well microtiter plates as described above before subjection to similar treatment with 278 
ciprofloxacin and HBOT as the 96 well plate biofilm assays. 279 
 280 
 281 
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Microscopy and image analysis 282 
With the use of a sterile 5 mm biopsy punch a cylindrical sample was taken from the central part of 283 
the wells in the 24-well microtiter plates. The cylindrical gel samples were cut in two halves each 284 
with a flat cut side. The cut samples were stained by applying 100 μL of a live/dead-stain mix of 285 
Syto9 (5 μM; Molecular Probes, USA) and propidium iodide (PI) (20 μM; Thermo Fisher, USA) in 286 
MiliQ water. The stained samples were incubated in the dark for 15 min at room temperature, 287 
before being placed flat-cut side down on coverslips. 288 
Samples were evaluated by confocal laser scanning microscopy (CLSM) on an LSM 880 Zeiss 289 
inverted microscope running Zen 2012 (Zeiss, Germany). The samples were imaged at 100x 290 
magnification by parallel tracks running 488 nm and 561 nm Lasers exciting Syto9 and PI, 291 
respectively. Samples were imaged with a 1 x 6 tile scan (1416 μm x 7091 μm) and over a depth of 292 
136 μm in z-direction. Obtained z-stacks were rendered into 3D projections and created in Imaris 293 
8.3 (Bitplane, Switzerland). 294 
Size and biomass of aggregates in CLSM image was measured with the use of the Measure Pro 295 
Expansion to Imaris 8.3. An iso-surface was applied over the Syto9 stained biomass as well as 296 
biomass stained with PI. Iso-surface particles larger than 100 um3 were consisted. All aggregates 297 
within a depth of 100 µm from the surface of the gel were measured, and returned as a measured 298 
volume. The radius of aggregates was calculated based on the assumption that aggregates were 299 
spherical. For fractionation of live and dead cells, the sum of biomass between Syto9 and PI was 300 
used as total biomass. A fraction of both Syto9 and PI of the total biomass was then used as an 301 
estimate of live and dead cells.  302 
 303 
 304 
 305 
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Oxygen measurements  306 
A 3 day old untreated biofilm in a 24-well microtiter plate was treated for 90 min with HBOT. 307 
Within 1 min of ending the experiment the microtiter plate was positioned on a heated metal rack, 308 
kept at 37oC and vertical micro-profiles of O2 concentration were recorded using a computer-309 
controlled micromanipulator (Pyro Science GmbH, Germany) equipped with a fiber-optic O2 310 
microsensor (50 μm tip diameter; Pyro Science GmbH, Germany) that was connected to a fiber-311 
optic O2 meter (FireSting2, Pyro Science GmbH, Germany). The microsensor was calibrated 312 
according to the manufacturer’s recommendations (air saturated and O2 free water). As the sample 313 
was kept at 37ºC this temperature was set as measurement temperature in the software. The 314 
microsensor was positioned manually at the base of the biofilm sample and profile measurements 315 
were taken by moving the sensor in vertical steps of 100 μm through the biofilm sample. 316 
Positioning and data acquisition were controlled by dedicated software (Profix version 4.51, Pyro 317 
Science).  318 
 319 
Oxygen diffusion (control) 320 
Diffusion of oxygen in gels without cells was compared between agarose concentrations 0.125% - 321 
2% with NaCl concentration 0.9 g L-1. The gels were placed in test tubes of 65 mm height and inner 322 
diameter 12 mm and left to congeal. Heights of the agarose gels ranged from 21 - 41 mm. Hereafter 323 
100 μL saline water (0.9 g L-1) was added on top of the gel to avoid drying and the tubes were 324 
sealed with parafilm. The test tubes were placed in an anaerobic chamber (Concept 400 from Baker 325 
Ruskinn) at 37 oC for at least 8 days to deoxygenate. The tip of the fiber-optic O2 micro sensor 326 
(OXR50-UHS from Pyroscience) was then positioned at 6 mm depth and the oxygen level was 327 
recorded under normoxic conditions as the gel re-oxygenated.  328 
 329 
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Statistical methods 330 
Statistical significance was evaluated by ordinary one or two-way analysis of variance (ANOVA) 331 
followed by Dunnett’s or Bonferroni’s multiple comparison test respectively and by Students T-test. 332 
A P-value of ≤ 0.05 was considered statistically significant. Data from at least 3 independent 333 
experiments were compared. Tests were performed with GraphPad Prism 6.1 (GraphPad Software 334 
Inc., La Jolla, CA) and Microsoft Excel (Microsoft Corp., Redmond, WA). 335 
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Figures 538 
 539 
Figure 1: Effect of simultaneous hyperbaric oxygen treatment (HBOT) on ciprofloxacin 540 
(0.25–2 mg L-1) treatment of anaerobic Pseudomonas aeruginosa biofilms a, Effect of anoxic 541 
(dotted line) and HBOT (filled line) conditions on % surviving cells on agarose embedded PAO1 542 
biofilms to ciprofloxacin (calculated as Δlog10 cell numbers) after treatment for 90 min. Bars 543 
indicate the mean ± standard error of the mean (n = 13-19). b, Effect of ciprofloxacin- and HBO-544 
treatment on 3-day-old agarose embedded biofilms of PAO1 (filled line) and ΔkatA (dotted line) 545 
(calculated as Δlog10 cell numbers) after treatment for 90 min. Bars indicate the mean ± standard 546 
error of the mean (n = 11-14). Significant changes (p ≤ 0.05) by particular ciprofloxacin 547 
concentrations are indicated by asterisks (*). Statistical significance was evaluated by a two-way 548 
ANOVA test followed by Bonferroni’s multiple comparison tests.  549 
 550 
 551 
 552 
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 553 
 554 
Figure 2: Lethality of ciprofloxacin-treated agarose-embedded Pseudomonas aeruginosa 555 
biofilms during anoxic or HBOT conditions.ciprofloxacin- and HBO-treated 3-day-old agarose 556 
imbedded biofilms of PAO1. Ciprofloxacin (0.25–2 mg L-1) treatment in anoxic agarose embedded 557 
biofilms of PAO1 and in HBOT agarose embedded biofilms of PAO1. The samples has been 558 
stained with Syto9 and propidium iodide (PI) and obtained by using a 63 x 1.4 NA Zeiss objective 559 
on a Zeiss 710 CLSM. Red denotes bacterial membranes that are permeable to PI (dead bacteria); 560 
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green bacteria are alive, since they have intact membranes that are not permeable to PI. The bar in 561 
the photograph represents 500 μm. (n = 1). 562 
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 579 
Figure 3: Hyperbaric oxygen treatment (HBOT) effect on bacterial growth in Pseudomonas 580 
aeruginosa biofilms. Effect of anoxic (circles) and HBOT (squares) conditions on bacterial growth 581 
(calculated as Δlog10 cell numbers) after treatment for 90 min on agarose embedded PAO1 biofilms. 582 
Bars indicate the mean ± standard error of the mean (n = 19). Statistical significance (p ≤ 0.05) was 583 
evaluated by the Student t-test.  584 
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 595 
Figure 4: Optical microsensor measurement of the chemical gradient of O2 in ciprofloxacin-596 
treated agarose-embedded Pseudomonas aeruginosa biofilm. Representative micro-profiling of 597 
the spatio-temporal dynamics of O2 in an agarose embedded PAO1 biofilm receiving HBOT for 90 598 
min showing initial accumulation of O2 in the media above the biofilm surface and inside the 599 
biofilm followed by depletion. The measurement of the O2 concentration profile was initiated 4 min 600 
after termination of HBOT with following profiling. 601 
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